Search

everythinglearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Apple polyphenol, especially oligomeric procyanidins, can reduce fat absorption and lower blood fat levels.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Allopregnanolone, a progesterone metabolite, helps reduce restraint effects on behavior.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Targeting the PGD2-DP2 pathway may help treat hair loss.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Progesterone's anesthetic effects don't rely on progesterone receptors.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.